Poster presentations at ISPOR US
June 2007
Pharmerit International presented two posters at the ISPOR congress on May 19-23, 2007 in the US.
The following posters were presented:
CLINICAL AND ECONOMIC OUTCOMES OF VANCOMYCIN FOR GRAM-POSITIVE INFECTIONS IN AN ERA OF INCREASING RESISTANCE: A SYSTEMATIC REVIEW
Stephens J1, Damen J2, Lesher B1, Foley I1, Haider S3
1PharMerit North America LLC, Bethesda, MD, USA, 2PharMerit BV, Rotterdam, The Netherlands, 3Pfizer Inc, Groton, CT, USA
LIFETIME ECONOMIC VALUE OF ORTHOPEDIC SURGERY WITH RECOMBINANT ACTIVATED FACTOR VII IN HEMOPHILIA PATIENTS WITH INHIBITORS
Ballal R1, Joshi AV2, Stephens JM3, Botteman MF3
1Georgetown University, Washington, DC, USA, 2Novo Nordisk Inc, Princeton, NJ, USA, 3PharMerit North America LLC, Bethesda, MD, USA